Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (21684)	10/23/2006 3:35:40 PM
From: Arthur Radley	Respond to of 52153

A very interesting article in current BusinessWeek about a new basket of ETFs that should come to market within weeks. What is unique about this new breed of ETF is that they will invest in specific disease categories...cancer,gastronintestinal,etc. They will be called HealthShares and should benefit the mid-to-lower cap biotechs as they will exclude the large cap companies. There are already 19 health-related ETFs, but again this will be the first disease specific...will be interesting to see which companies are deemed worthy of such investing. Can only hope I hold a few of them...(:>)